Literature DB >> 22350746

CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease.

Hyo Jin Park1, Dahye Byun, An Hi Lee, Ju Hyun Kim, Young Larn Ban, Masatake Araki, Kimi Araki, Ken-Ichi Yamamura, Inho Kim, Seong Hoe Park, Kyeong Cheon Jung.   

Abstract

CD99 is involved in many cellular events, such as the generation of Hodgkin and Reed-Sternberg cells, T cell costimulation, and leukocyte transendothelial migration. However, these studies have been limited to in vitro or in vivo experiments using CD99-deficient cell lines or anti-CD99 antibodies. In the present study, using CD99-deficient mice established by the exchangeable gene trap method, we investigated the physiologic function of murine CD99. In a B6 splenocytes → bm12 graft-versus-host disease model, wild-type cells were minimally lethal, whereas all mice that received CD99-deficient donor cells developed an early and more severe pathology. Graftversus-host disease in these mice was associated with insufficient expansion of myeloid-derived suppressor cells. This was confirmed by experiments illustrating that the injection of wild-type donor cells depleted of Mac-1(+) cells led to an almost identical disease course as the CD99-deficient donor system. Therefore, these results suggest that CD99 plays a crucial role in the attenuation of graft-versus-host disease by regulating the expansion of myeloid-derived suppressor cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350746      PMCID: PMC3887710          DOI: 10.1007/s10059-012-2227-z

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  32 in total

1.  Apoptosis of immature thymocytes mediated by E2/CD99.

Authors:  G Bernard; J P Breittmayer; M de Matteis; P Trampont; P Hofman; A Senik; A Bernard
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

2.  Split tolerance in spleen chimeras.

Authors:  J Sprent; M Hurd; M Schaefer; W Heath
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

3.  Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.

Authors:  Eun Kyung Lee; Ji Hye Chae; Myung-Soo Kang
Journal:  Mol Cells       Date:  2011-10-19       Impact factor: 5.034

4.  Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype.

Authors:  S H Kim; Y K Shin; I S Lee; Y M Bae; H W Sohn; Y H Suh; H J Ree; M Rowe; S H Park
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

5.  CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.

Authors:  Arun R Rao; Marlon P Quinones; Edgar Garavito; Yogeshwar Kalkonde; Fabio Jimenez; Caroline Gibbons; Jennifer Perez; Peter Melby; William Kuziel; Robert L Reddick; Sunil K Ahuja; Seema S Ahuja
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

6.  High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Authors:  Paolo Serafini; Rebecca Carbley; Kimberly A Noonan; Gladys Tan; Vincenzo Bronte; Ivan Borrello
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

7.  Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.

Authors:  Qingsheng Li; Ping-Ying Pan; Peidi Gu; Dongping Xu; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

8.  Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo.

Authors:  A A Vaporciyan; H M DeLisser; H C Yan; I I Mendiguren; S R Thom; M L Jones; P A Ward; S M Albelda
Journal:  Science       Date:  1993-12-03       Impact factor: 47.728

9.  Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD.

Authors:  J Sprent; M Schaefer; R Korngold
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

10.  Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor.

Authors:  Ikuo Shiratori; Kouetsu Ogasawara; Takashi Saito; Lewis L Lanier; Hisashi Arase
Journal:  J Exp Med       Date:  2004-02-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.